Author Question: The nurse is assessing a male client who has epididymitis. Which statement by the nurse would ... (Read 69 times)

2125004343 · **on:** Jun 25, 2018

The nurse is assessing a male client who has epididymitis. Which statement by the nurse would provide appropriate education regarding this condition?

1. You will have a decrease in testosterone production.
2. Your sperm maturity may be affected.
3. There will be a decrease in blood flow to your penis.
4. There may be erectile difficulties.

Question 2

The nurse is conducting a health interview for a 55-year-old client who presents to the clinic for an annual physical examination. The client questions the need to begin screening for prostate cancer at this examination.

Which response by the nurse is the most appropriate?
1. Unless you are at an increased risk for the development of prostate cancer no additional screening indicated.
2. PSA screening tests should be performed once you reach age 75.
3. You need to begin having an annual prostate examination.
4. A cystoscopy should be performed annually to assess for prostate changes at age 55.

rosiehomeworddo · **Reply #1 on:** Jun 25, 2018

Answer to Question 1

Correct Answer: 2
The epididymis is the final area for the storage and maturation of sperm. Inflammation of the epididymis can impact the sperm's maturity. The epididymis does not produce testosterone. The epididymis does not impact the blood flow to the penis. The epididymis does not have an influence on the ability to achieve an erection.

Answer to Question 2

Correct Answer: 3
Annual prostate examination is recommended for males after the age of 50. The United States Preventive Task Force (USPSTF) has issued recommendations regarding the use of the prostate specific antigen (PSA) screening. The USPSTF recommends against PSA screening in males 75 years of age and older. In men younger than 75 the recommendations are to review individual risk factors to determine the use of the test. Cystoscopy is a diagnostic test that allows for a scope to be inserted through the urethra to view the bladder. It is not used to diagnose prostate cancer.